1887

fThe development of monoclonal antibodies to block the action of NGF (Zoetis sponsored symposium)

image of The development of monoclonal antibodies to block the action of NGF (Zoetis sponsored symposium)

Abstract

This presentation reviews the role of NGF in joint pain, provides an overview of the medications that have been available for osteoarthritis (OA) pain over the past 30 years and moves on to introduce anti-NGF monoclonal antibody as a new therapeutic class for the management of OA pain.

Loading full text...

Full text loading...

/content/chapter/10.22233/9781913859008.Ch164

Supplements

More like this

/content/chapter/10.22233/9781913859008.Ch164
dcterms_title,dcterms_description
-contentType:Journal
5
5
Loading ...

Loading ...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error